EFFICACY AND SAFETY OF RANIBIZUMAB FOR THE TREATMENT OF CHOROIDAL NEOVASCULARIZATION DUE TO UNCOMMON CAUSE-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

EFFICACY AND SAFETY OF RANIBIZUMAB FOR THE TREATMENT OF CHOROIDAL NEOVASCULARIZATION DUE TO UNCOMMON CAUSE

Published:2018-08 Issue:8 Volume:38 Page:1464-1477
ISSN:0275-004X
Container-title:Retina
language:en
Short-container-title:

Author:

Lai Timothy Y. Y.,Staurenghi Giovanni,Lanzetta Paolo,Holz Frank G.,Melissa Liew Shiao Hui,Desset-Brethes Sabine,Staines Harry,Hykin Philip G.,

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology,General Medicine

Reference57 articles.

1. Clincopathologic correlations of surgically excised type 1 and type 2 submacular choroidal neovsacular membranes;Grossniklaus;Am J Ophthalmol,1998

2. Ranibizumab treatment for choroidal neovascularization from causes other than age-related macular degeneration and pathological myopia;Carneiro;Ophthalmologica,2011

3. Choroidal neovascularisation in children;Sivaprasad;Br J Ophthalmol,2008

4. Etiology of choroidal neovascularization in young patients;Cohen;Ophthalmology,1996

5. The epidemiology of age-related macular degeneration;Klein;Am J Ophthalmol,2004

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pseudoxanthoma elasticum – Genetics, pathophysiology, and clinical presentation;Progress in Retinal and Eye Research;2024-09

2. Anti-VEGF Treatment for Secondary Neovascularization in Pseudoxanthoma Elasticum - Age of Onset, Treatment Frequency, and Visual Outcome;American Journal of Ophthalmology;2024-09

3. Unilateral Vogt-Koyanagi-Harada Disease With Two Distinct Choroidal Neovascular Membranes: A Case Report;Cureus;2024-08-07

4. Macular neovascularization;Survey of Ophthalmology;2024-08

5. Central serous chorioretinopathy: An evidence-based treatment guideline;Progress in Retinal and Eye Research;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3